Effect of Transtympanic Injection of Melatonin on Cisplatin-Induced Ototoxicity
Author(s) -
Mehmet Gökhan Demir,
Niyazi Altıntoprak,
Sedat Aydın,
Ebru Kösemihal,
Kayhan Başak
Publication year - 2016
Publication title -
the journal of international advanced otology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.518
H-Index - 13
eISSN - 2148-3817
pISSN - 1308-7649
DOI - 10.5152/iao.2015.1094
Subject(s) - ototoxicity , melatonin , medicine , cisplatin , intraperitoneal injection , auditory brainstem response , saline , otoacoustic emission , hearing loss , anesthesia , pharmacology , endocrinology , audiology , chemotherapy
Cisplatin is a chemotherapeutic agent that is widely used in cancer treatment. Numerous side effects have been detected, one of which is ototoxicity. Melatonin, a product of the pineal gland, has a neuroendocrinoimmunological role in vertebrates. In the present study, we investigated the effects of melatonin on cisplatin-induced ototoxicity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom